Reddy S, Smith D B, Rich M M, Leferovich J M, Reilly P, Davis B M, Tran K, Rayburn H, Bronson R, Cros D, Balice-Gordon R J, Housman D
Center for Cancer Research, M.I.T. Cambridge, Massachusetts 02138, USA.
Nat Genet. 1996 Jul;13(3):325-35. doi: 10.1038/ng0796-325.
Myotonic dystrophy (DM) is an autosomal dominant disorder resulting from the expansion of a CTG repeat in the 3' untranslated region of a putative protein kinase (DMPK). To elucidate the role of DMPK in DM pathogenesis we have developed Dmpk deficient (Dmpk-/-) mice. Dmpk-/-mice develop a late-onset, progressive skeletal myopathy that shares some pathological features with DM. Muscles from mature mice show variation in fibre size, increased fibre degeneration and fibrosis. Adult Dmpk-/-mice show ultrastructural changes in muscle and a 50% decrease in force generation compared to young mice. Our results indicate that DMPK may be necessary for the maintenance of skeletal muscle structure and function and suggest that a decrease in DMPK levels may contribute to DM pathology.
强直性肌营养不良(DM)是一种常染色体显性疾病,由假定的蛋白激酶(DMPK)的3'非翻译区中CTG重复序列的扩增引起。为了阐明DMPK在DM发病机制中的作用,我们培育出了Dmpk基因缺陷(Dmpk-/-)小鼠。Dmpk-/-小鼠会出现迟发性进行性骨骼肌病,该病与DM有一些共同的病理特征。成熟小鼠的肌肉显示出纤维大小的差异、纤维变性增加和纤维化。与年轻小鼠相比,成年Dmpk-/-小鼠的肌肉出现超微结构变化,且力量产生减少50%。我们的结果表明,DMPK可能是维持骨骼肌结构和功能所必需的,并提示DMPK水平的降低可能导致DM病理改变。